Literature DB >> 25711669

User-driven development of a web-based tool for patient reporting of drug-related harm.

Monica Plöen1, Magnus Wallberg, Sten Olsson.   

Abstract

Commissioned by the Monitoring Medicines project, the Uppsala Monitoring Centre (UMC) led the design and development of a web-based ADR (adverse drug reaction) reporting tool intended for use by patients. The software design was undertaken in close collaboration with representatives of national pharmacovigilance centres (NPCs) and with patient and consumer organizations. The web-based tool was developed by these participants through several telephone conferences, a workshop and site testing. The tool is directly compatible with the UMC's Individual Case Safety Report (ICSR) data management system VigiFlow(®) and is also compliant with the ICH-E2B(R2) format. The UMC team benefited by working closely with the end-users during the development process. A major challenge was to balance the need for detailed information required by the NPCs to be able to assess reports with the amount of detail patients are able and willing to provide. Needs, ideas and suggestions from the end users were valuable and were taken into account throughout the process of designing the tool.

Entities:  

Mesh:

Year:  2015        PMID: 25711669     DOI: 10.1007/s40264-015-0276-x

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  5 in total

Review 1.  Experiences with adverse drug reaction reporting by patients: an 11-country survey.

Authors:  Florence van Hunsel; Linda Härmark; Shanthi Pal; Sten Olsson; Kees van Grootheest
Journal:  Drug Saf       Date:  2012-01-01       Impact factor: 5.606

2.  Performance of probabilistic method to detect duplicate individual case safety reports.

Authors:  Philip Michael Tregunno; Dorthe Bech Fink; Cristina Fernandez-Fernandez; Edurne Lázaro-Bengoa; G Niklas Norén
Journal:  Drug Saf       Date:  2014-04       Impact factor: 5.606

3.  The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control study.

Authors:  Florence van Hunsel; Attje Talsma; Eugène van Puijenbroek; Lolkje de Jong-van den Berg; Kees van Grootheest
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-12-28       Impact factor: 2.890

Review 4.  Under-reporting of adverse drug reactions : a systematic review.

Authors:  Lorna Hazell; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

5.  Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidance.

Authors:  Anjan K Banerjee; Sally Okun; I Ralph Edwards; Paul Wicks; Meredith Y Smith; Stephen J Mayall; Bruno Flamion; Charles Cleeland; Ethan Basch
Journal:  Drug Saf       Date:  2013-12       Impact factor: 5.606

  5 in total
  3 in total

1.  Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities' Views and Needs.

Authors:  Cristiano Matos; Linda Härmark; Florence van Hunsel
Journal:  Drug Saf       Date:  2016-11       Impact factor: 5.606

2.  The monitoring medicines project: a multinational pharmacovigilance and public health project.

Authors:  Shanthi N Pal; Sten Olsson; Elliot G Brown
Journal:  Drug Saf       Date:  2015-04       Impact factor: 5.606

3.  Artificial intelligence in pharmacovigilance: Practical utility.

Authors:  Kotni Murali; Sukhmeet Kaur; Ajay Prakash; Bikash Medhi
Journal:  Indian J Pharmacol       Date:  2020-01-16       Impact factor: 1.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.